rs61758388

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_022166.4(XYLT1):​c.343G>T​(p.Ala115Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0268 in 1,230,650 control chromosomes in the GnomAD database, including 523 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.019 ( 49 hom., cov: 31)
Exomes 𝑓: 0.028 ( 474 hom. )

Consequence

XYLT1
NM_022166.4 missense

Scores

2
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5O:1

Conservation

PhyloP100: 0.397

Publications

19 publications found
Variant links:
Genes affected
XYLT1 (HGNC:15516): (xylosyltransferase 1) This locus encodes a xylosyltransferase enzyme. The encoded protein catalyzes transfer of UDP-xylose to serine residues of an acceptor protein substrate. This transfer reaction is necessary for biosynthesis of glycosaminoglycan chains. Mutations in this gene have been associated with increased severity of pseudoxanthoma elasticum.[provided by RefSeq, Nov 2009]
XYLT1 Gene-Disease associations (from GenCC):
  • Desbuquois dysplasia 2
    Inheritance: AR Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Desbuquois dysplasia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • XYLT1-congenital disorder of glycosylation
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.013451189).
BP6
Variant 16-17470454-C-A is Benign according to our data. Variant chr16-17470454-C-A is described in ClinVar as Benign. ClinVar VariationId is 2534.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0187 (2844/151954) while in subpopulation NFE AF = 0.0293 (1989/67872). AF 95% confidence interval is 0.0282. There are 49 homozygotes in GnomAd4. There are 1313 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 49 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
XYLT1NM_022166.4 linkc.343G>T p.Ala115Ser missense_variant Exon 1 of 12 ENST00000261381.7 NP_071449.1 Q86Y38
XYLT1XM_047434458.1 linkc.343G>T p.Ala115Ser missense_variant Exon 1 of 11 XP_047290414.1
XYLT1XM_017023539.3 linkc.343G>T p.Ala115Ser missense_variant Exon 1 of 12 XP_016879028.1
LOC107987234XR_001752091.2 linkn.-27G>T upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
XYLT1ENST00000261381.7 linkc.343G>T p.Ala115Ser missense_variant Exon 1 of 12 1 NM_022166.4 ENSP00000261381.6 Q86Y38

Frequencies

GnomAD3 genomes
AF:
0.0187
AC:
2845
AN:
151840
Hom.:
49
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00524
Gnomad AMI
AF:
0.0747
Gnomad AMR
AF:
0.0182
Gnomad ASJ
AF:
0.0346
Gnomad EAS
AF:
0.000195
Gnomad SAS
AF:
0.00518
Gnomad FIN
AF:
0.00890
Gnomad MID
AF:
0.0191
Gnomad NFE
AF:
0.0293
Gnomad OTH
AF:
0.0225
GnomAD2 exomes
AF:
0.0273
AC:
27
AN:
988
AF XY:
0.0234
show subpopulations
Gnomad AFR exome
AF:
0.0250
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.0357
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0297
Gnomad OTH exome
AF:
0.0294
GnomAD4 exome
AF:
0.0280
AC:
30184
AN:
1078696
Hom.:
474
Cov.:
30
AF XY:
0.0279
AC XY:
14220
AN XY:
510138
show subpopulations
African (AFR)
AF:
0.00374
AC:
85
AN:
22736
American (AMR)
AF:
0.0114
AC:
95
AN:
8306
Ashkenazi Jewish (ASJ)
AF:
0.0329
AC:
466
AN:
14180
East Asian (EAS)
AF:
0.00
AC:
0
AN:
26402
South Asian (SAS)
AF:
0.00455
AC:
92
AN:
20234
European-Finnish (FIN)
AF:
0.00807
AC:
170
AN:
21072
Middle Eastern (MID)
AF:
0.0204
AC:
66
AN:
3232
European-Non Finnish (NFE)
AF:
0.0307
AC:
28176
AN:
919108
Other (OTH)
AF:
0.0238
AC:
1034
AN:
43426
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1828
3656
5484
7312
9140
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1234
2468
3702
4936
6170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0187
AC:
2844
AN:
151954
Hom.:
49
Cov.:
31
AF XY:
0.0177
AC XY:
1313
AN XY:
74270
show subpopulations
African (AFR)
AF:
0.00522
AC:
217
AN:
41540
American (AMR)
AF:
0.0181
AC:
277
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.0346
AC:
120
AN:
3464
East Asian (EAS)
AF:
0.000196
AC:
1
AN:
5106
South Asian (SAS)
AF:
0.00518
AC:
25
AN:
4822
European-Finnish (FIN)
AF:
0.00890
AC:
94
AN:
10558
Middle Eastern (MID)
AF:
0.0205
AC:
6
AN:
292
European-Non Finnish (NFE)
AF:
0.0293
AC:
1989
AN:
67872
Other (OTH)
AF:
0.0223
AC:
47
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
141
282
424
565
706
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0161
Hom.:
10
Bravo
AF:
0.0181
ExAC
AF:
0.00598
AC:
316
Asia WGS
AF:
0.00289
AC:
10
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:5Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Sep 30, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 19014925, 16759312, 16571645) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Desbuquois dysplasia 2 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Desbuquois dysplasia 1 Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive inherited pseudoxanthoma elasticum;C4014294:Desbuquois dysplasia 2 Benign:1
Feb 06, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

PSEUDOXANTHOMA ELASTICUM, MODIFIER OF SEVERITY OF Other:1
Sep 01, 2006
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.70
T
BayesDel_noAF
Benign
-0.75
CADD
Benign
16
DANN
Uncertain
0.98
DEOGEN2
Benign
0.0093
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.36
N
MetaRNN
Benign
0.013
T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
0.0
N
PhyloP100
0.40
PrimateAI
Uncertain
0.76
T
PROVEAN
Benign
-0.010
N
REVEL
Benign
0.021
Sift
Benign
0.41
T
Sift4G
Benign
0.50
T
Polyphen
0.0010
B
Vest4
0.024
MPC
0.20
ClinPred
0.0042
T
GERP RS
1.8
Varity_R
0.082
gMVP
0.12
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61758388; hg19: chr16-17564311; COSMIC: COSV54477311; API